Cancer News
« Men who eat soy may have lower lung cancer risk - Reuters
Lung cancer ‘increasing’ in Wales - BBC News »

Tough Questions Await Cell Therapeutics’ Cancer Drug - Wall Street Journal (blog)


TheStreet.com
Tough Questions Await Cell Therapeutics' Cancer Drug
Wall Street Journal (blog)
Cell Therapeutics' experimental lymphoma drug pixantrone faces rough sledding from an FDA advisory committee after an agency staff review ...
FDA: Limited Clinical Data On Proposed Cancer Drug PixantroneWall Street Journal
FDA Raises Concerns About Cell Therapeutics Cancer DrugTheStreet.com

all 34 news articles »

This entry was posted on Monday, February 8th, 2010 at 5:43 PM and filed under Cancer News.
Follow comments here with the RSS 2.0 (XML) feed. Post a comment or leave a trackback.

Post a Comment

You must be logged in to post a comment.

This information is not intended to replace the advice of a doctor. Cancer1News.com disclaims any liability for the decisions you make based on this information.